4892 — Cyfuse Biomedical KK Share Price
0.000.00%
Last trade - 00:00- ¥8bn
- ¥6bn
- ¥54m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.16 | ||
| Price to Tang. Book | 3.17 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 147.62 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -31.23% | ||
| Return on Equity | -30.36% | ||
| Operating Margin | -1645.91% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 137.48 | 708.25 | 374.48 | 61.11 | 54.45 | n/a | n/a | -20.67% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cyfuse Biomedical KK is a Japan-based company mainly engaged in the research, development, manufacture and sale of cell products. The Company is engaged in the development of pipelines for obtaining approval for regenerative medicine products and contract research cell products in the field of regenerative medicine. The Company is engaged in the development of cell products as tools for drug discovery support for pharmaceutical companies in the drug discovery support field. The Company is engaged in the development and sell of three-dimensional cell stacking system equipment equipped with basic technology, apply technology for cell product development, and develop new technology in the device field.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 11th, 2010
- Public Since
- December 1st, 2022
- No. of Shareholders
- 6,285
- No. of Employees
- 21
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 8,304,800
- Address
- 5A, ICN Bldg., 2-27-17, Hongo, MINATO-KU, 108-6301
- Web
- https://www.cyfusebio.com/
- Phone
- +81 364351885
- Auditors
- Toho Audit Corporation
Upcoming Events for 4892
Dividend For 4892.T - 0.0000 JPY
Similar to 4892
3-D Matrix
Tokyo Stock Exchange
AnGes
Tokyo Stock Exchange
BrightPath Biotherapeutics Co
Tokyo Stock Exchange
Carna Biosciences
Tokyo Stock Exchange
Chiome Bioscience
Tokyo Stock Exchange
FAQ
What is the Cyfuse Biomedical KK share price?
As of Today at 20:08 UTC, shares in Cyfuse Biomedical KK are trading at ¥982. This share price information is delayed by 15 minutes.
How has the Cyfuse Biomedical KK share price performed this year?
Shares in Cyfuse Biomedical KK last closed at ¥982 and the price had moved by +40.89% over the past 365 days. In terms of relative price strength the Cyfuse Biomedical KK share price has outperformed the Nikkei 225 Index by +48.48% over the past year.
What are the analyst and broker recommendations for Cyfuse Biomedical KK?
There is no consensus recommendation for this security.
Find out moreWhat is the Cyfuse Biomedical KK dividend yield?
Cyfuse Biomedical KK does not currently pay a dividend.
Does Cyfuse Biomedical KK pay a dividend?
Cyfuse Biomedical KK does not currently pay a dividend.
When does Cyfuse Biomedical KK next pay dividends?
Cyfuse Biomedical KK does not currently pay a dividend.
How do I buy Cyfuse Biomedical KK shares?
To buy shares in Cyfuse Biomedical KK you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Cyfuse Biomedical KK?
As of the previous close price of ¥982, shares in Cyfuse Biomedical KK had a market capitalisation of ¥8bn.
Where are Cyfuse Biomedical KK shares listed?
Here are the trading details for Cyfuse Biomedical KK:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4892
What kind of share is Cyfuse Biomedical KK?
Based on an overall assessment of its quality, value and momentum Cyfuse Biomedical KK is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Cyfuse Biomedical KK share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Cyfuse Biomedical KK share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cyfuse Biomedical KK. Over the past six months, its share price has outperformed the Nikkei 225 Index by +94.1%.
As of the last closing price of ¥982, shares in Cyfuse Biomedical KK were trading +43.96% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Cyfuse Biomedical KK PE Ratio?
The Cyfuse Biomedical KK PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥982.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Cyfuse Biomedical KK?
We do not have data on Cyfuse Biomedical KK's directors